Newsroom

November 4, 2021
Third quarter GAAP net sales of $1.16 billion , an increase of 3% year-over-year; non-GAAP organic net sales increased 3% year-over-year Third quarter GAAP net loss attributable to Covetrus of $(4) million versus GAAP net loss attributable to Covetrus of $(35) million in the prior year period;
August 5, 2021
Second quarter GAAP net sales of $1.19 billion , an increase of 16% year-over-year; non-GAAP organic net sales increased 12% year-over-year Second quarter GAAP net loss attributable to Covetrus of $31 million versus GAAP net income of $54 million in the prior year period; second quarter non-GAAP
August 5, 2021
ESG commitments help illustrate company’s culture and benchmark future goals PORTLAND, Maine --(BUSINESS WIRE)--Aug. 5, 2021-- Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, today released its first Environmental, Social and Governance report since forming just
July 22, 2021
Drew Coxhead brings deep accounting experience to support Covetrus’ transformation PORTLAND, Maine --(BUSINESS WIRE)--Jul. 22, 2021-- Covetrus ® (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that Drew Coxhead will be appointed as vice president, corporate
June 30, 2021
Animal health leader to combine practice, prescription, and wellness management for better veterinarian-client relationships, practice revenue and healthcare outcomes. PORTLAND, Maine & IRVINE, Calif. --(BUSINESS WIRE)--Jun. 30, 2021-- Covetrus® (NASDAQ: CVET), a global leader in animal-health
June 6, 2021
Digital scripts drive health, growth and wellness for busy veterinary clinics PORTLAND, Maine --(BUSINESS WIRE)--Jun. 6, 2021-- Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, announced an enhancement to their leading practice management software to help today’s